Related Experiment Video
Updated: Jan 8, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Current Management Strategies for Stenotrophomonas maltophilia
Ya-Ting Chang1, Po-Liang Lu2, David L Paterson3
1ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, Singapore; Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Abstract:
Optimal therapeutic strategies for Stenotrophomonas maltophilia infections remain largely undefined. Current evidence tentatively supports combination therapy in immunocompromised hosts and severe infections, as no single agent reliably provides bactericidal activity. However, no specific regimen has been proven superior. Traditional agents such as trimethoprim-sulfamethoxazole, minocycline, and levofloxacin remain essential components of treatment. New antimicrobials, including cefiderocol and aztreonam-avibactam, are promising options, but further clinical data are required to validate their efficacy. To date, no randomized controlled trials have been conducted in S maltophilia infections, and well-designed studies are urgently needed to provide definitive answers.
Insights
Optimal treatment for Stenotrophomonas maltophilia infections is unclear. Combination therapy may benefit severe cases, but no regimen is proven superior, necessitating further research into effective antimicrobial strategies.
Area of Science:
- Infectious Diseases
- Medical Microbiology
- Pharmacology
Background:
- Stenotrophomonas maltophilia infections pose significant therapeutic challenges due to undefined optimal treatment strategies.
- Current evidence suggests combination therapy for immunocompromised patients and severe infections, but lacks definitive superiority data.
- No single antimicrobial agent consistently demonstrates reliable bactericidal activity against this pathogen.
Purpose of the Study:
- To review current therapeutic strategies for Stenotrophomonas maltophilia infections.
- To identify gaps in clinical evidence regarding treatment efficacy.
- To highlight the need for rigorous clinical trials to establish optimal treatment regimens.
Main Methods:
- Literature review of existing evidence on Stenotrophomonas maltophilia treatment.
- Analysis of traditional and novel antimicrobial agents.
- Assessment of the current state of clinical trial data.
Main Results:
- Traditional agents like trimethoprim-sulfamethoxazole, minocycline, and levofloxacin remain crucial.
- Emerging agents such as cefiderocol and aztreonam-avibactam show promise but require further validation.
- No randomized controlled trials have been published for S. maltophilia infections.
Conclusions:
- Optimal therapeutic strategies for Stenotrophomonas maltophilia infections are not well-defined.
- Well-designed clinical studies are urgently required to guide treatment decisions.
- Further research is needed to validate novel agents and confirm the superiority of specific regimens.
More Related Videos
08:03A Tandem Liquid Chromatography–Mass Spectrometry-based Approach for Metabolite Analysis of Staphylococcus aureus
Published on: March 28, 2017
07:44Time-Lapse Epifluorescence Microscopy Imaging of Pseudomonas aeruginosa and Staphylococcus aureus Heterogeneous Phenotypes
Published on: February 14, 2025
Related Concept Videos
Methods for Controlling Microbial Growth
Biological Methods for Microbial Control
Key Techniques in Microbiology
Special Staining Techniques